Opting for COVID-19 Vaccine: Yes versus No
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Published
Sep 29, 2024
Abstract
The COVID-19 vaccine has unquestionably provided a multitude of advantages in the fight against the global pandemic. The virus has resulted in a substantial decrease in infection rates, hospitalizations, and fatalities as a result of its successful development and distribution. Individuals can contribute to the collective effort to attain herd immunity and end the spread of COVID-19 by receiving the vaccine, which will protect them and those around them. Nevertheless, it is crucial to recognize a few of the vaccine’s downsides. These may encompass temporary side effects, such as muscle soreness or fatigue, as well as concerns regarding the long-term effectiveness and potential unforeseen risks. The COVID-19 vaccine is a critical weapon in the fight against this unprecedented public health crisis, as the benefits of receiving it far outweigh any potential risks, despite the drawbacks.
##plugins.themes.bootstrap3.article.details##
Keywords
COVID-19, Vaccine, Pandemic, Benefits versus Drawbacks, Immunity
Supporting Agencies
No funding source declared.
References
Adler, J. M., Vidal, R. M., Langner, C., Vladimirova, D., Abdelgawad, A., Kunecova, D., Lin, X., Nouailles, G., Voss, A., Kunder, S., Gruber, A. D., Wu, H., Osterrieder, N., Kunec, D., & Trimpert, J. (2024). An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission. Nature Communications, 15(1). DOI: https://doi.org/10.1038/s41467-024-45348-2
Afrashtehfar, K. I., Jurado, C. A., Abu-Fanas, S. H., & Jaber, M. A. (2023). Health and well-being through COVID-19 vaccination: Physical, oral, and psychological effects. International Journal of Environmental Research and Public Health, 20(4), 3117. DOI: https://doi.org/10.3390/ijerph20043117
Alazzam, F. a. F., Shakatreh, H. J. M., Gharaibeh, Z. I. Y., Aldrou, K. K. a. R., & Alkhatib, A. J. (2022). COVID-19 vaccinations: Medical, ethical and legal aspects. Medical Archives, 76(6), 413. DOI: https://doi.org/10.5455/medarh.2022.76.413-418
Alsuwaidi, A. R., Hammad, H. a. A., Elbarazi, I., & Sheek-Hussein, M. (2023). Vaccine hesitancy within the Muslim community: Islamic faith and public health perspectives. Human Vaccines & Immunotherapeutics, 19(1). DOI: https://doi.org/10.1080/21645515.2023.2190716
Artenstein, A. W., & Grabenstein, J. D. (2008). Smallpox vaccines for biodefense: Need and feasibility. Expert Review of Vaccines, 7(8), 1225-1237. DOI: https://doi.org/10.1586/14760584.7.8.1225
Bohmwald, K., Diethelm-Varela, B., Rodríguez-Guilarte, L., Rivera, T., Riedel, C. A., González, P. A., & Kalergis, A. M. (2024). Pathophysiological, immunological, and inflammatory features of long COVID. Frontiers in Immunology, 15. DOI: https://doi.org/10.3389/fimmu.2024.1341600
Cankat, S., Demael, M. U., & Swadling, L. (2023). In search of a pan-coronavirus vaccine: Next-generation vaccine design and immune mechanisms. Cellular and Molecular Immunology, 21(2), 103-118. DOI: https://doi.org/10.1038/s41423-023-01116-8
Cerda, A. A., & García, L. Y. (2021). Hesitation and refusal factors in individuals’ decision-making processes regarding a coronavirus disease 2019 vaccination. Frontiers in Public Health, 9. DOI: https://doi.org/10.3389/fpubh.2021.626852
Chakraborty, C., Bhattacharya, M., & Dhama, K. (2023). SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: The lessons learned might help to fight against the next pandemic. Vaccines, 11(3), 682. DOI: https://doi.org/10.3390/vaccines11030682
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022). Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. The Journal of Infectious Diseases, 226(9), 1593-1607. DOI: https://doi.org/10.1093/infdis/jiac136
Del Cura-Bilbao, A., López-Mendoza, H., Chaure-Pardos, A., Vergara-Ugarriza, A., & Guimbao-Bescós, J. (2022). Effectiveness of 3 COVID-19 vaccines in preventing SARS-CoV-2 infections, January-May 2021, Aragon, Spain. Emerging Infectious Diseases, 28(3), 591-598. DOI: https://doi.org/10.3201/eid2803.212027
Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., Kwong, J., Macartney, K., Naus, M., Grange, Z., Escolano, S., Sepulveda, G., Shetty, A., Pillsbury, A., Sullivan, C., Naveed, Z., Janjua, N., Giglio, N., Perälä, J., . . . Hviid, A. (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. DOI: https://doi.org/10.1016/j.vaccine.2024.01.100
Goldin, S., Moen, A., Moss, W. J., & Nuzzo, J. (2024). The 2020 immunization programme landscape: Piloting an assessment metric to evaluate the maturity of national immunization programmes across the life course. Vaccine. DOI: https://doi.org/10.1016/j.vaccine.2023.12.051
Hartner, A., Li, X., Echeverria-Londono, S., Roth, J., Abbas, K., Auzenbergs, M., De Villiers, M. J., Ferrari, M. J., Fraser, K., Fu, H., Hallett, T., Hinsley, W., Jit, M., Karachaliou, A., Moore, S. M., Nayagam, S., Papadopoulos, T., Perkins, T. A., Portnoy, A., . . . Gaythorpe, K. a. M. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: A modelling study. The Lancet Global Health, 12(4), e563-e571. DOI: https://doi.org/10.1016/s2214-109x(23)00603-4
Hinman, A. (1999). Eradication of vaccine-preventable diseases. Annual Review of Public Health, 20(1), 211-229. DOI: https://doi.org/10.1146/annurev.publhealth.20.1.211
Hồ, N. T., Hughes, S. G., Ta, V. T., Phan, L. T., Đỗ, Q., Nguyễn, T. V., Phạm, A. T. V., Đặng, M. T. N., Nguyễn, L. V., Trịnh, Q. V., Phạm, H. N., Chử, M. V., Nguyễn, T. T., Lương, Q. C., Lê, V. T. T., Nguyễn, T. V., Trần, L., Van Luu, A. T., Nguyen, A. N., . . . Nguyen, X. (2024). Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: Pooled phase 1, 2, 3a and 3b randomized, controlled trials. Nature Communications, 15(1). DOI: https://doi.org/10.1038/s41467-024-47905-1
Iserson, K. V. (2020). SARS-CoV-2 (COVID-19) Vaccine development and production: An ethical way forward. Cambridge Quarterly of Healthcare Ethics, 30(1), 59-68. DOI: https://doi.org/10.1017/s096318012000047x
Jamaludin, S., Azmir, N. A., Ayob, A. F. M., & Zainal, N. (2020). COVID-19 exit strategy: Transitioning towards a new normal. Annals of Medicine and Surgery, 59, 165-170. DOI: https://doi.org/10.1016/j.amsu.2020.09.046
Kashte, S., Gulbake, A., El-Amin, S. F., III, & Gupta, A. (2021). COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Human Cell, 34(3), 711-733. DOI: https://doi.org/10.1007/s13577-021-00512-4
Koneru, A., Wells, K., Carnes, C. A., Drumhiller, K., Chatham-Stephens, K., Melton, M., Oliphant, H., Hall, S., Dennison, C., Fiscus, M., & Vogt, T. (2024). A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years. Vaccine. DOI: https://doi.org/10.1016/j.vaccine.2024.03.064
Krammer, F. (2023). The role of vaccines in the COVID-19 pandemic: What have we learned? Seminars in Immunopathology. DOI: https://doi.org/10.1007/s00281-023-00996-2
Machekanyanga, Z., Ndiaye, S., Gerede, R., Chindedza, K., Chigodo, C., Shibeshi, M. E., Goodson, J., Daniel, F., Zimmerman, L., & Kaiser, R. (2017). Qualitative assessment of vaccination hesitancy among members of the apostolic church of Zimbabwe: A case study. Journal of Religion and Health, 56(5), 1683-1691. DOI: https://doi.org/10.1007/s10943-017-0428-7
Mao, Z., Li, Q., Wang, Y., & Zhou, J. (2024). Pro-religion attitude predicts lower vaccination coverage at country level. Humanities and Social Sciences Communications, 11(1). DOI: https://doi.org/10.1057/s41599-023-02598-7
Marks, P., & Califf, R. (2024). Is vaccination approaching a dangerous tipping point? JAMA, 331(4), 283. DOI: https://doi.org/10.1001/jama.2023.27685
Mazidimoradi, A., Allahqoli, L., & Salehiniya, H. (2023). The ambiguous future of the COVID-19 pandemic in the presence of a vaccine. Health Science Reports, 6(4). DOI: https://doi.org/10.1002/hsr2.1207
Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 mRNA vaccines: Lessons learned from the registrational trials and global vaccination campaign. Cureus. DOI: https://doi.org/10.7759/cureus.52876
Mohammed, I., Nauman, A., Paul, P., Ganesan, S., Chen, K., Jalil, S. M. S., Jaouni, S. H., Kawas, H., Khan, W. A., Vattoth, A. L., Al-Hashimi, Y. A., Fares, A., Zeghlache, R., & Zakaria, D. (2022). The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Human Vaccines & Immunotherapeutics, 18(1). DOI: https://doi.org/10.1080/21645515.2022.2027160
Mostafa, R. H., & Moustafa, A. (2024). Beyond acute infection: Molecular mechanisms underpinning cardiovascular complications in long COVID. Frontiers in Cardiovascular Medicine, 11. DOI: https://doi.org/10.3389/fcvm.2024.1268571
Orenstein, W. A., & Ahmed, R. (2017). Simply put: Vaccination saves lives. Proceedings of the National Academy of Sciences, 114(16), 4031-4033. DOI: https://doi.org/10.1073/pnas.1704507114
Park, H. J., Gonsalves, G. S., Tan, S. T., Kelly, J. D., Rutherford, G. W., Wachter, R. M., Schechter, R., Paltiel, A. D., & Lo, N. C. (2024). Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States. Nature Communications, 15(1). DOI: https://doi.org/10.1038/s41467-024-45549-9
Patryn, R. K., & Zagaja, A. (2016). Vaccinations—Between free will and coercion. Human Vaccines & Immunotherapeutics, 12(8), 2204-2205. DOI: https://doi.org/10.1080/21645515.2016.1162936
Pietzner, M., Denaxas, S., Yasmeen, S., Ulmer, M. A., Nakanishi, T., Arnold, M., Kastenmüller, G., Hemingway, H., & Langenberg, C. (2024). Complex patterns of multimorbidity associated with severe COVID-19 and long COVID. Communications Medicine, 4(1). DOI: https://doi.org/10.1038/s43856-024-00506-x
Polykretis, P., Donzelli, A., Lindsay, J. C., Wiseman, D., Kyriakopoulos, A. M., Mörz, M., Bellavite, P., Fukushima, M., Seneff, S., & McCullough, P. A. (2023). Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues. Autoimmunity, 56(1). DOI: https://doi.org/10.1080/08916934.2023.2259123
Prasad, V., & Haslam, A. (2024). COVID-19 vaccines: History of the pandemic’s great scientific success and flawed policy implementation. Bioethics News. DOI: https://doi.org/10.1007/s40592-024-00189-z
Rahmani, K., Shavaleh, R., Forouhi, M., Disfani, H. F., Kamandi, M., Oskooi, R. K., Foogerdi, M., Soltani, M., Rahchamani, M., Mohaddespour, M., & Dianatinasab, M. (2022). The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis. Frontiers in Public Health, 10. DOI: https://doi.org/10.3389/fpubh.2022.873596
Rana, R., Kant, R., Kumra, T., Gupta, S., Rana, D. S., & Ganguly, N. K. (2023). An update on SARS-CoV-2 immunization and future directions. Frontiers in Pharmacology, 14. DOI: https://doi.org/10.3389/fphar.2023.1125305
Rashi, T. (2023). Priority of vaccination of the population against COVID-19: Moral principles. Vaccines, 11(2), 380. DOI: https://doi.org/10.3390/vaccines11020380
Rodriguez-Morales, A. J., Lopez-Echeverri, M. C., Perez-Raga, M. F., Quintero-Romero, V., Valencia-Gallego, V., Galindo-Herrera, N., López-Alzate, S., Sánchez-Vinasco, J. D., Gutiérrez-Vargas, J. J., Mayta-Tristan, P., Husni, R., Moghnieh, R., Stephan, J., Faour, W., Tawil, S., Barakat, H., Chaaban, T., Megarbane, A., Rizk, Y., . . . Ulloa-Gutiérrez, R. (2023). The global challenges of the long COVID-19 in adults and children. Travel Medicine and Infectious Disease, 54, 102606. DOI: https://doi.org/10.1016/j.tmaid.2023.102606
Šalamon, Š., Ewing, A., Fox, G., Bilodeau, S., Gershenson, C., Heino, M. T., & Bar-Yam, Y. (2024). SARS-CoV-2 and COVID-19: From crisis to solution. WHN Science Communications, 5(1), 1. DOI: https://doi.org/10.59454/whn-2401-334
Seyedin, H., Zanganeh, A., Mojtabaei, M., Bagherzadeh, R., & Faghihi, H. (2020). A model of reopening businesses to decrease the heath and economic impacts of the COVID-19 pandemic: Lessons from Iran. The Medical Journal of the Islamic Republic of Iran, 34(1), 97. DOI: https://doi.org/10.34171/mjiri.34.97
Shi, T., Robertson, C., & Sheikh, A. (2023). Effectiveness and safety of coronavirus disease 2019 vaccines. Current Opinion in Pulmonary Medicine, 29(3), 138-142. DOI: https://doi.org/10.1097/mcp.0000000000000948
Srivastava, K., Carreño, J. M., Gleason, C., Monahan, B., Singh, G., Abbad, A., Tcheou, J., Raskin, A., Kleiner, G., Van Bakel, H., Sordillo, E. M., Krammer, F., Simon, V., Alshammary, H., Amoako, A. A., Andre, D., Awawda, M., Bermúdez-González, M. C., Beach, K. F., . . . Wajnberg, A. (2024). SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity, 57(3), 587-599.e4. DOI: https://doi.org/10.1016/j.immuni.2024.01.017
Stoddard, M., Sarkar, S., Yuan, L., Nolan, R. P., White, D. E., White, L. F., Hochberg, N. S., & Chakravarty, A. (2021). Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2. PLoS ONE, 16(7), e0254734. DOI: https://doi.org/10.1371/journal.pone.0254734
Unfried, K., & Priebe, J. (2024). Vaccine hesitancy and trust in sub-Saharan Africa. Scientific Reports, 14(1). DOI: https://doi.org/10.1038/s41598-024-61205-0
Wu, N., Joyal-Desmarais, K., Ribeiro, P. a. B., Vieira, A. M., Stojanovic, J., Sanuade, C., Yip, D., & Bacon, S. L. (2023). Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: Findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. The Lancet Respiratory Medicine, 11(5), 439-452. DOI: https://doi.org/10.1016/s2213-2600(23)00015-2
Yoder, J. S., & Dworkin, M. S. (2006). Vaccination usage among an old-order Amish community in Illinois. The Pediatric Infectious Disease Journal, 25(12), 1182-1183. DOI: https://doi.org/10.1097/01.inf.0000246851.19000.3e
Zhang, Y., Bharathi, V., Dokoshi, T., De Anda, J., Ursery, L. T., Kulkarni, N. N., Nakamura, Y., Chen, J., Luo, E. W. C., Wang, L., Xu, H., Coady, A., Zurich, R., Lee, M. W., Matsui, T., Lee, H., Chan, L. C., Schepmoes, A. A., Lipton, M. S., . . . Wong, G. C. L. (2024). Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes. Proceedings of the National Academy of Sciences, 121(6). DOI: https://doi.org/10.1073/pnas.2300644120
Zheng, Y., Zeng, N., Yuan, K., Tian, S., Yang, Y., Gao, N., Chen, X., Zhang, A., Kondratiuk, A. L., Shi, P., Zhang, F., Sun, J., Yue, J., Lin, X., Shi, L., Lalvani, A., Shi, J., Bao, Y., & Lu, L. (2023). Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. Journal of Infection and Public Health, 16(5), 660-672. DOI: https://doi.org/10.1016/j.jiph.2023.03.005
Afrashtehfar, K. I., Jurado, C. A., Abu-Fanas, S. H., & Jaber, M. A. (2023). Health and well-being through COVID-19 vaccination: Physical, oral, and psychological effects. International Journal of Environmental Research and Public Health, 20(4), 3117. DOI: https://doi.org/10.3390/ijerph20043117
Alazzam, F. a. F., Shakatreh, H. J. M., Gharaibeh, Z. I. Y., Aldrou, K. K. a. R., & Alkhatib, A. J. (2022). COVID-19 vaccinations: Medical, ethical and legal aspects. Medical Archives, 76(6), 413. DOI: https://doi.org/10.5455/medarh.2022.76.413-418
Alsuwaidi, A. R., Hammad, H. a. A., Elbarazi, I., & Sheek-Hussein, M. (2023). Vaccine hesitancy within the Muslim community: Islamic faith and public health perspectives. Human Vaccines & Immunotherapeutics, 19(1). DOI: https://doi.org/10.1080/21645515.2023.2190716
Artenstein, A. W., & Grabenstein, J. D. (2008). Smallpox vaccines for biodefense: Need and feasibility. Expert Review of Vaccines, 7(8), 1225-1237. DOI: https://doi.org/10.1586/14760584.7.8.1225
Bohmwald, K., Diethelm-Varela, B., Rodríguez-Guilarte, L., Rivera, T., Riedel, C. A., González, P. A., & Kalergis, A. M. (2024). Pathophysiological, immunological, and inflammatory features of long COVID. Frontiers in Immunology, 15. DOI: https://doi.org/10.3389/fimmu.2024.1341600
Cankat, S., Demael, M. U., & Swadling, L. (2023). In search of a pan-coronavirus vaccine: Next-generation vaccine design and immune mechanisms. Cellular and Molecular Immunology, 21(2), 103-118. DOI: https://doi.org/10.1038/s41423-023-01116-8
Cerda, A. A., & García, L. Y. (2021). Hesitation and refusal factors in individuals’ decision-making processes regarding a coronavirus disease 2019 vaccination. Frontiers in Public Health, 9. DOI: https://doi.org/10.3389/fpubh.2021.626852
Chakraborty, C., Bhattacharya, M., & Dhama, K. (2023). SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: The lessons learned might help to fight against the next pandemic. Vaccines, 11(3), 682. DOI: https://doi.org/10.3390/vaccines11030682
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022). Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. The Journal of Infectious Diseases, 226(9), 1593-1607. DOI: https://doi.org/10.1093/infdis/jiac136
Del Cura-Bilbao, A., López-Mendoza, H., Chaure-Pardos, A., Vergara-Ugarriza, A., & Guimbao-Bescós, J. (2022). Effectiveness of 3 COVID-19 vaccines in preventing SARS-CoV-2 infections, January-May 2021, Aragon, Spain. Emerging Infectious Diseases, 28(3), 591-598. DOI: https://doi.org/10.3201/eid2803.212027
Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., Kwong, J., Macartney, K., Naus, M., Grange, Z., Escolano, S., Sepulveda, G., Shetty, A., Pillsbury, A., Sullivan, C., Naveed, Z., Janjua, N., Giglio, N., Perälä, J., . . . Hviid, A. (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. DOI: https://doi.org/10.1016/j.vaccine.2024.01.100
Goldin, S., Moen, A., Moss, W. J., & Nuzzo, J. (2024). The 2020 immunization programme landscape: Piloting an assessment metric to evaluate the maturity of national immunization programmes across the life course. Vaccine. DOI: https://doi.org/10.1016/j.vaccine.2023.12.051
Hartner, A., Li, X., Echeverria-Londono, S., Roth, J., Abbas, K., Auzenbergs, M., De Villiers, M. J., Ferrari, M. J., Fraser, K., Fu, H., Hallett, T., Hinsley, W., Jit, M., Karachaliou, A., Moore, S. M., Nayagam, S., Papadopoulos, T., Perkins, T. A., Portnoy, A., . . . Gaythorpe, K. a. M. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: A modelling study. The Lancet Global Health, 12(4), e563-e571. DOI: https://doi.org/10.1016/s2214-109x(23)00603-4
Hinman, A. (1999). Eradication of vaccine-preventable diseases. Annual Review of Public Health, 20(1), 211-229. DOI: https://doi.org/10.1146/annurev.publhealth.20.1.211
Hồ, N. T., Hughes, S. G., Ta, V. T., Phan, L. T., Đỗ, Q., Nguyễn, T. V., Phạm, A. T. V., Đặng, M. T. N., Nguyễn, L. V., Trịnh, Q. V., Phạm, H. N., Chử, M. V., Nguyễn, T. T., Lương, Q. C., Lê, V. T. T., Nguyễn, T. V., Trần, L., Van Luu, A. T., Nguyen, A. N., . . . Nguyen, X. (2024). Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: Pooled phase 1, 2, 3a and 3b randomized, controlled trials. Nature Communications, 15(1). DOI: https://doi.org/10.1038/s41467-024-47905-1
Iserson, K. V. (2020). SARS-CoV-2 (COVID-19) Vaccine development and production: An ethical way forward. Cambridge Quarterly of Healthcare Ethics, 30(1), 59-68. DOI: https://doi.org/10.1017/s096318012000047x
Jamaludin, S., Azmir, N. A., Ayob, A. F. M., & Zainal, N. (2020). COVID-19 exit strategy: Transitioning towards a new normal. Annals of Medicine and Surgery, 59, 165-170. DOI: https://doi.org/10.1016/j.amsu.2020.09.046
Kashte, S., Gulbake, A., El-Amin, S. F., III, & Gupta, A. (2021). COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Human Cell, 34(3), 711-733. DOI: https://doi.org/10.1007/s13577-021-00512-4
Koneru, A., Wells, K., Carnes, C. A., Drumhiller, K., Chatham-Stephens, K., Melton, M., Oliphant, H., Hall, S., Dennison, C., Fiscus, M., & Vogt, T. (2024). A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years. Vaccine. DOI: https://doi.org/10.1016/j.vaccine.2024.03.064
Krammer, F. (2023). The role of vaccines in the COVID-19 pandemic: What have we learned? Seminars in Immunopathology. DOI: https://doi.org/10.1007/s00281-023-00996-2
Machekanyanga, Z., Ndiaye, S., Gerede, R., Chindedza, K., Chigodo, C., Shibeshi, M. E., Goodson, J., Daniel, F., Zimmerman, L., & Kaiser, R. (2017). Qualitative assessment of vaccination hesitancy among members of the apostolic church of Zimbabwe: A case study. Journal of Religion and Health, 56(5), 1683-1691. DOI: https://doi.org/10.1007/s10943-017-0428-7
Mao, Z., Li, Q., Wang, Y., & Zhou, J. (2024). Pro-religion attitude predicts lower vaccination coverage at country level. Humanities and Social Sciences Communications, 11(1). DOI: https://doi.org/10.1057/s41599-023-02598-7
Marks, P., & Califf, R. (2024). Is vaccination approaching a dangerous tipping point? JAMA, 331(4), 283. DOI: https://doi.org/10.1001/jama.2023.27685
Mazidimoradi, A., Allahqoli, L., & Salehiniya, H. (2023). The ambiguous future of the COVID-19 pandemic in the presence of a vaccine. Health Science Reports, 6(4). DOI: https://doi.org/10.1002/hsr2.1207
Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 mRNA vaccines: Lessons learned from the registrational trials and global vaccination campaign. Cureus. DOI: https://doi.org/10.7759/cureus.52876
Mohammed, I., Nauman, A., Paul, P., Ganesan, S., Chen, K., Jalil, S. M. S., Jaouni, S. H., Kawas, H., Khan, W. A., Vattoth, A. L., Al-Hashimi, Y. A., Fares, A., Zeghlache, R., & Zakaria, D. (2022). The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Human Vaccines & Immunotherapeutics, 18(1). DOI: https://doi.org/10.1080/21645515.2022.2027160
Mostafa, R. H., & Moustafa, A. (2024). Beyond acute infection: Molecular mechanisms underpinning cardiovascular complications in long COVID. Frontiers in Cardiovascular Medicine, 11. DOI: https://doi.org/10.3389/fcvm.2024.1268571
Orenstein, W. A., & Ahmed, R. (2017). Simply put: Vaccination saves lives. Proceedings of the National Academy of Sciences, 114(16), 4031-4033. DOI: https://doi.org/10.1073/pnas.1704507114
Park, H. J., Gonsalves, G. S., Tan, S. T., Kelly, J. D., Rutherford, G. W., Wachter, R. M., Schechter, R., Paltiel, A. D., & Lo, N. C. (2024). Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States. Nature Communications, 15(1). DOI: https://doi.org/10.1038/s41467-024-45549-9
Patryn, R. K., & Zagaja, A. (2016). Vaccinations—Between free will and coercion. Human Vaccines & Immunotherapeutics, 12(8), 2204-2205. DOI: https://doi.org/10.1080/21645515.2016.1162936
Pietzner, M., Denaxas, S., Yasmeen, S., Ulmer, M. A., Nakanishi, T., Arnold, M., Kastenmüller, G., Hemingway, H., & Langenberg, C. (2024). Complex patterns of multimorbidity associated with severe COVID-19 and long COVID. Communications Medicine, 4(1). DOI: https://doi.org/10.1038/s43856-024-00506-x
Polykretis, P., Donzelli, A., Lindsay, J. C., Wiseman, D., Kyriakopoulos, A. M., Mörz, M., Bellavite, P., Fukushima, M., Seneff, S., & McCullough, P. A. (2023). Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues. Autoimmunity, 56(1). DOI: https://doi.org/10.1080/08916934.2023.2259123
Prasad, V., & Haslam, A. (2024). COVID-19 vaccines: History of the pandemic’s great scientific success and flawed policy implementation. Bioethics News. DOI: https://doi.org/10.1007/s40592-024-00189-z
Rahmani, K., Shavaleh, R., Forouhi, M., Disfani, H. F., Kamandi, M., Oskooi, R. K., Foogerdi, M., Soltani, M., Rahchamani, M., Mohaddespour, M., & Dianatinasab, M. (2022). The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis. Frontiers in Public Health, 10. DOI: https://doi.org/10.3389/fpubh.2022.873596
Rana, R., Kant, R., Kumra, T., Gupta, S., Rana, D. S., & Ganguly, N. K. (2023). An update on SARS-CoV-2 immunization and future directions. Frontiers in Pharmacology, 14. DOI: https://doi.org/10.3389/fphar.2023.1125305
Rashi, T. (2023). Priority of vaccination of the population against COVID-19: Moral principles. Vaccines, 11(2), 380. DOI: https://doi.org/10.3390/vaccines11020380
Rodriguez-Morales, A. J., Lopez-Echeverri, M. C., Perez-Raga, M. F., Quintero-Romero, V., Valencia-Gallego, V., Galindo-Herrera, N., López-Alzate, S., Sánchez-Vinasco, J. D., Gutiérrez-Vargas, J. J., Mayta-Tristan, P., Husni, R., Moghnieh, R., Stephan, J., Faour, W., Tawil, S., Barakat, H., Chaaban, T., Megarbane, A., Rizk, Y., . . . Ulloa-Gutiérrez, R. (2023). The global challenges of the long COVID-19 in adults and children. Travel Medicine and Infectious Disease, 54, 102606. DOI: https://doi.org/10.1016/j.tmaid.2023.102606
Šalamon, Š., Ewing, A., Fox, G., Bilodeau, S., Gershenson, C., Heino, M. T., & Bar-Yam, Y. (2024). SARS-CoV-2 and COVID-19: From crisis to solution. WHN Science Communications, 5(1), 1. DOI: https://doi.org/10.59454/whn-2401-334
Seyedin, H., Zanganeh, A., Mojtabaei, M., Bagherzadeh, R., & Faghihi, H. (2020). A model of reopening businesses to decrease the heath and economic impacts of the COVID-19 pandemic: Lessons from Iran. The Medical Journal of the Islamic Republic of Iran, 34(1), 97. DOI: https://doi.org/10.34171/mjiri.34.97
Shi, T., Robertson, C., & Sheikh, A. (2023). Effectiveness and safety of coronavirus disease 2019 vaccines. Current Opinion in Pulmonary Medicine, 29(3), 138-142. DOI: https://doi.org/10.1097/mcp.0000000000000948
Srivastava, K., Carreño, J. M., Gleason, C., Monahan, B., Singh, G., Abbad, A., Tcheou, J., Raskin, A., Kleiner, G., Van Bakel, H., Sordillo, E. M., Krammer, F., Simon, V., Alshammary, H., Amoako, A. A., Andre, D., Awawda, M., Bermúdez-González, M. C., Beach, K. F., . . . Wajnberg, A. (2024). SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity, 57(3), 587-599.e4. DOI: https://doi.org/10.1016/j.immuni.2024.01.017
Stoddard, M., Sarkar, S., Yuan, L., Nolan, R. P., White, D. E., White, L. F., Hochberg, N. S., & Chakravarty, A. (2021). Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2. PLoS ONE, 16(7), e0254734. DOI: https://doi.org/10.1371/journal.pone.0254734
Unfried, K., & Priebe, J. (2024). Vaccine hesitancy and trust in sub-Saharan Africa. Scientific Reports, 14(1). DOI: https://doi.org/10.1038/s41598-024-61205-0
Wu, N., Joyal-Desmarais, K., Ribeiro, P. a. B., Vieira, A. M., Stojanovic, J., Sanuade, C., Yip, D., & Bacon, S. L. (2023). Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: Findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. The Lancet Respiratory Medicine, 11(5), 439-452. DOI: https://doi.org/10.1016/s2213-2600(23)00015-2
Yoder, J. S., & Dworkin, M. S. (2006). Vaccination usage among an old-order Amish community in Illinois. The Pediatric Infectious Disease Journal, 25(12), 1182-1183. DOI: https://doi.org/10.1097/01.inf.0000246851.19000.3e
Zhang, Y., Bharathi, V., Dokoshi, T., De Anda, J., Ursery, L. T., Kulkarni, N. N., Nakamura, Y., Chen, J., Luo, E. W. C., Wang, L., Xu, H., Coady, A., Zurich, R., Lee, M. W., Matsui, T., Lee, H., Chan, L. C., Schepmoes, A. A., Lipton, M. S., . . . Wong, G. C. L. (2024). Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes. Proceedings of the National Academy of Sciences, 121(6). DOI: https://doi.org/10.1073/pnas.2300644120
Zheng, Y., Zeng, N., Yuan, K., Tian, S., Yang, Y., Gao, N., Chen, X., Zhang, A., Kondratiuk, A. L., Shi, P., Zhang, F., Sun, J., Yue, J., Lin, X., Shi, L., Lalvani, A., Shi, J., Bao, Y., & Lu, L. (2023). Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. Journal of Infection and Public Health, 16(5), 660-672. DOI: https://doi.org/10.1016/j.jiph.2023.03.005
How to Cite
Han, D. (2024). Opting for COVID-19 Vaccine: Yes versus No. Science Insights, 45(3), 1491–1495. https://doi.org/10.15354/si.24.ed085
Section
Editorial
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.